| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AFMD | Exit | AFFIMED N V | $0 | – | -1,428,571 | -100.0% | -0.07% | – |
| Exit | RALLYBIO CORP | $0 | – | -268,532 | -100.0% | -0.10% | – | |
| OLMA | Exit | OLEMA PHARMACEUTICALS INC | $0 | – | -77,042 | -100.0% | -0.10% | – |
| AGLE | Exit | AEGLEA BIOTHERAPEUTICS INC | $0 | – | -295,034 | -100.0% | -0.38% | – |
| LYRA | Exit | LYRA THERAPEUTICS INC | $0 | – | -924,170 | -100.0% | -0.38% | – |
| Exit | SAGIMET BIOSCIENCES INC | $0 | – | -515,000 | -100.0% | -0.48% | – | |
| PLRX | Exit | PLIANT THERAPEUTICS INC | $0 | – | -288,949 | -100.0% | -0.53% | – |
| MIST | Exit | MILESTONE PHARMACEUTICALS IN | $0 | – | -2,208,812 | -100.0% | -0.72% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -1,040,754 | -100.0% | -0.75% | – |
| TRVI | Exit | TREVI THERAPEUTICS INC | $0 | – | -3,422,397 | -100.0% | -0.78% | – |
| Exit | ACELYRIN INC | $0 | – | -864,332 | -100.0% | -0.92% | – | |
| PRAX | Exit | PRAXIS PRECISION MEDICINES I | $0 | – | -5,304,410 | -100.0% | -0.96% | – |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -6,573,300 | -100.0% | -1.04% | – |
| Exit | DIANTHUS THERAPEUTICS INC | $0 | – | -927,706 | -100.0% | -1.34% | – | |
| ORIC | Exit | ORIC PHARMACEUTICALS INC | $0 | – | -2,142,856 | -100.0% | -1.36% | – |
| APLT | Exit | APPLIED THERAPEUTICS INC | $0 | – | -5,658,034 | -100.0% | -1.48% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -11,328,000 | -100.0% | -1.51% | – |
| TERN | Exit | TERNS PHARMACEUTICALS INC | $0 | – | -3,092,273 | -100.0% | -1.64% | – |
| CELC | Exit | CELCUITY INC | $0 | – | -2,105,386 | -100.0% | -2.03% | – |
| DYN | Exit | DYNE THERAPEUTICS INC | $0 | – | -2,173,913 | -100.0% | -2.05% | – |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -2,623,677 | -100.0% | -2.47% | – |
| AMAM | Exit | AMBRX BIOPHARMA INCsponsored ads | $0 | – | -2,070,000 | -100.0% | -2.51% | – |
| RYTM | Exit | RHYTHM PHARMACEUTICALS INC | $0 | – | -1,090,000 | -100.0% | -2.63% | – |
| SVRA | Exit | SAVARA INC | $0 | – | -7,184,865 | -100.0% | -2.86% | – |
| Exit | HILLEVAX INC | $0 | – | -2,037,313 | -100.0% | -2.88% | – | |
| GHRS | Exit | GH RESEARCH PLCordinary shares | $0 | – | -2,744,125 | -100.0% | -2.90% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -2,916,667 | -100.0% | -2.96% | – |
| CABA | Exit | CABALETTA BIO INC | $0 | – | -1,973,253 | -100.0% | -3.16% | – |
| PHVS | Exit | PHARVARIS N V | $0 | – | -1,563,513 | -100.0% | -3.44% | – |
| FDMT | Exit | 4D MOLECULAR THERAPEUTICS IN | $0 | – | -3,000,000 | -100.0% | -4.02% | – |
| Exit | ENLIVEN THERAPEUTICS INC | $0 | – | -2,954,902 | -100.0% | -4.25% | – | |
| MRUS | Exit | MERUS N V | $0 | – | -1,726,214 | -100.0% | -4.28% | – |
| TSHA | Exit | TAYSHA GENE THERAPIES INC | $0 | – | -14,444,444 | -100.0% | -4.80% | – |
| COGT | Exit | COGENT BIOSCIENCES INC | $0 | – | -4,684,167 | -100.0% | -4.81% | – |
| VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -3,082,622 | -100.0% | -4.98% | – |
| Exit | RAYZEBIO INC | $0 | – | -4,016,847 | -100.0% | -9.39% | – | |
| Exit | APOGEE THERAPEUTICS INC | $0 | – | -8,493,321 | -100.0% | -19.04% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 12 | Q3 2023 | 12.7% |
| VIRIDIAN THERAPEUTICS INC | 12 | Q3 2023 | 13.4% |
| COGENT BIOSCIENCES INC | 12 | Q3 2023 | 10.3% |
| RELMADA THERAPEUTICS INC | 11 | Q3 2022 | 9.9% |
| GH RESEARCH PLC | 10 | Q3 2023 | 6.7% |
| ALTIMMUNE INC | 9 | Q3 2022 | 11.6% |
| MARINUS PHARMACEUTICALS INC | 9 | Q4 2022 | 5.7% |
| CELLDEX THERAPEUTICS INC | 9 | Q3 2022 | 7.6% |
| AFFIMED N V | 8 | Q3 2023 | 1.1% |
| INSTIL BIO INC | 7 | Q3 2022 | 18.7% |
View VR Adviser, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View VR Adviser, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.